Free Trial
LON:NCYT

Novacyt (NCYT) Share Price, News & Analysis

GBX 47.25
+0.75 (+1.61%)
(As of 07:29 AM ET)
Today's Range
46.74
47.70
50-Day Range
43.95
69.60
52-Week Range
39.07
86
Volume
9,776 shs
Average Volume
114,506 shs
Market Capitalization
£33.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NCYT stock logo

About Novacyt Stock (LON:NCYT)

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

NCYT Stock Price History

NCYT Stock News Headlines

Novacyt SA ALNOV
Long Term Incentive Plan
Who’s partnering with Nvidia next?
Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.
DHSC Claim update - Pre-Trial Review
AstraZeneca increases 2024 dividend by 7%
Directorate Changes and FY 23 results update
Update on Taiwanese divestment
Novacyt SA NYZ
Who’s partnering with Nvidia next?
Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.
Trading update
Reminder to shareholders re. AGM voting
Cancellation of trading of Yourgene Shares
Notice of rescheduled AGM
Yourgene jumps 143% on Novacyt £16.7m knock-out bid
Chipotle Mexica Share Chat
Nordtelekom Nyr Share Chat
Calipso Oradea Share Chat
Publication of Annual Report and AGM voting
See More Headlines
Receive NCYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Net Income
£-25,300,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.87 million
Cash Flow
GBX 82.18 per share
Book Value
GBX 152 per share

Miscellaneous

Free Float
N/A
Market Cap
£33.69 million
Optionable
Not Optionable
Beta
-1.80
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. James Martin McCarthy (Age 58)
    Acting CEO & Director
    Comp: $354.52k
  • Mr. Steve Gibson
    CFO & Director
  • Bryan Close
    Chief Operations Officer
  • Ms. Mandy Cowling
    Corporate & Investor Relations Manager
  • Mr. David Franks
    Chief Human Resources Officer
  • Paul Oladimeji
    Group Head of R&D
  • Mr. Lyn Dafydd Rees (Age 51)
    Executive Director

NCYT Stock Analysis - Frequently Asked Questions

How have NCYT shares performed this year?

Novacyt's stock was trading at GBX 61.50 at the beginning of the year. Since then, NCYT stock has decreased by 22.4% and is now trading at GBX 47.70.
View the best growth stocks for 2024 here
.

How do I buy shares of Novacyt?

Shares of NCYT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Novacyt own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Novacyt investors own include Biocept (BIOC), Ecolab (ECL), genedrive (GDR), Geron (GERN), Immunic (IMUX), Tiziana Life Sciences (TILS) and Verastem (VSTM).

This page (LON:NCYT) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners